I am a
Home I AM A Search Login

Papers of the Week


2020


Diabetes Metab Syndr Obes


13

Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus.

Authors

Albai O, Timar B, Paun D L, Sima A, Roman D, Timar R
Diabetes Metab Syndr Obes. 2020; 13:3873-3878.
PMID: 33116733.

Abstract

Vitamin B12 (cobalamin) deficiency is a frequent cause of megaloblastic anemia, manifested through various symptoms. Screening for this deficiency can be justified in case of patients with one or more risk factors present from the following: gastric resections, inflammatory bowel disease, use of metformin over a prolonged period of time, administration of proton pump inhibitors or H2 histamine receptor blockers for more than 12 months and in case of adults over 75 years of age. One method of determining vitamin B12 deficiency is measuring its serum levels, as well as performing measurements of serum levels of methylmalonic acid and homocysteine levels, which experience an increase in the early stages of vitamin B12 deficiency.